Indian Journal of Pharmaceutical Education and Research logo
Submit
Indian Journal of Pharmaceutical Education and ResearchAn Official Publication of Association of Pharmaceutical Teachers of India (APTI)
Review

Effects of Astaxanthin Supplement on Cardiovascular Health: A Systematic Review and Meta-Analysis

1, 2, 1, 3, 4, 5, 1, 1, 6, 1, 1, 1,2

  1. 1Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.
  2. 2College of Life Sciences, Hainan Normal University, Haikou, Hainan, CHINA.
  3. 3Academician Workstation, Changsha Medical University, Changsha, Hunan, CHINA.
  4. 4Guilin Medical University, Guilin, Guangxi, CHINA.
  5. 5Zunyi Medical University, Zunyi, Guizhou, CHINA.
  6. 6Lingkou Central Hospital of Ding'an County, Ding'an, Hainan, CHINA.

CORRESPONDENCE

Le Du, Key

Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, CHINA.

1250500226@qq.com

Received: 14-01-2024; Revised: 25-07-2024; Accepted: 05-04-2025.

Volume 59, Issue 3 · pp. 865-874 · 2025 · DOI: 10.5530/ijper.20256138

ABSTRACT

Background: The objective of this study was to evaluate the effects of astaxanthin intake on the cardiovascular disease-related indicators.Materials and Methods: Fives databases, including PUBMED, CNKI, WEIPU, WAN FANG and Clinical Trials were searched up to June 30, 2023. The random-effects model was used to calculate the summary risk. A total of 17 studies were included in this meta-analysis and a total of 1101 subjects' data were included in the analysis. In all included literature studies, a randomly assigned placebo group was established as the control. In the literature included, the average intervention dose of ASTX in the experimental group was 10.14 mg/day, with an average duration of administration of 68 days.Results: The overall study did not show a significant association between Astaxanthin (ASTX) and Systolic Blood Pressure (SBP) (standardized mean difference, SMD: -0.03, 95% CI: -0.22 to 0.17, p=0.771), Diastolic Blood Pressure (DBP) (SMD: -0.16, 95% CI: -0.35 to 0.03, p=0.100), the glucose concentration (SMD: -0.12, 95% CI: -0.39 to 0.15, p=0.398) and Body Mass Index (BMI) (SMD: -0.02, 95% CI: -0.22 to 0.18, p=0.821). However, the results revealed that astaxanthin can significantly reduce total cholesterol concentration (SMD: -0.20, 95% CI: -0.37 to -0.04, p=0.000), low-density lipoprotein cholesterol concentration (LDL-C) (SMD: -0.25, 95% CI: -0.41 to -0.09, p=0.003) and triglyceride concentration (SMD: -0.17, 95% CI: -0.32 to -0.01, p=0.033). Furthermore, astaxanthin could increase the concentrations of high-density lipoprotein cholesterol (HDL-C) (SMD: 0.18, 95% CI: 0.05 to 0.32, p=0.008).Conclusion: The results of this meta-analysis indicate that astaxanthin intake can significantly improve hyperlipidemia. Further studies are needed to validate these findings and investigate the potential cardiovascular benefits of astaxanthin.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Liu, Y., Mo, W., Ye, H., Bao, M., Long, Z., Kou, R., Qiao, P., Meng, R., Chen, R., He, R., Du, L., & Gao, X. (2025). Effects of Astaxanthin Supplement on Cardiovascular Health: A Systematic Review and Meta-Analysis. Indian Journal of Pharmaceutical Education and Research, 59(3), 865-874. https://doi.org/10.5530/ijper.20256138

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0